Budesonide/formoterol - EMS
Alternative Names: Flamboyant 125/12; Formoterol/budesonide - EMSLatest Information Update: 01 Aug 2022
At a glance
- Originator EMS
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Bronchodilators; Ethanolamines; Glucocorticoids; Pregnenediones; Small molecules
- Mechanism of Action Beta 2 adrenergic receptor agonists; Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Asthma
Most Recent Events
- 22 Jul 2022 Phase-III clinical trials in Asthma in Brazil (Inhalation) (NCT04191434)
- 24 Feb 2021 EMS plans a phase III trial in Asthma (NCT04191434)
- 24 Feb 2021 Preclinical trials in Asthma in Brazil (Inhalation) (NCT04191434)